No Data
Carna Biosciences 9-Mos Loss Y1.59B Vs Loss Y1.23B
Carna Biosciences: Financial results presentation materials for the 3rd quarter of the fiscal year ending 2024/12
Carna Biosciences: Summary of Financial Results for the 3rd Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)
Morinaga Milk, mcdonald's, Toyo Suisan, Eisai (8th) (1429-5463)
※Please note that the above calendar is tentative and subject to change based on the company's convenience. --------------------------------------- November 8th (Fri) <1429> Japan Aqua <1435> RoboHome <143A> Ishin <1450> Tanaka Construction Industry <1451> KHC <1518> Mitsui Matsushima HD <151A> Dai <167A> Ryo
Active and newly listed stocks during the morning session.
*Raccoon HD <3031> 782 +66 announced the implementation of a high-level share buyback program, leading to expectations of supply and demand. *Aeon Fantasy <4343> 2395 +170 Short covering predominant due to the movements in the earnings revision. *USC <4732> 1279 +27 Speculative buying also seen in response to the news of an on-site inspection by IDOM. *Mitsubishi Motors <7211> 408.6 +4.7 Clues include progress in yen depreciation and other factors. *Epson <6724> 2820.5 +29
Insider decrases its stake in Carna Biosciences(4572.JP) to 3.33%
On Oct 21, モルガン・スタンレー・アンド・カンパニー・インターナショナル・ピーエルシー and related parties submitted the Change Report to Ministry of Finance. The report shows that モルガン・スタンレー・アンド・カンパニー・インターナショナル・ピーエルシー and
No Data
No Data